Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Atopic Dermatitis”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02424253
What this trial is testing

Determine the Efficacy of ZPL-3893787 in Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Ziarco Pharma Ltd 98
Large-scale testing (Phase 3)Study completedNCT00691145
What this trial is testing

Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Astellas Pharma Inc 350
Not applicableNot Yet RecruitingNCT04730024
What this trial is testing

Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj

Who this might be right for
Atopic Dermatitis
Kang Stem Biotech Co., Ltd. 102
Early research (Phase 1)Study completedNCT03514511
What this trial is testing

Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
LEO Pharma 47
Not applicableLooking for participantsNCT03057860
What this trial is testing

TREATgermany: German National Clinical Registry for Patients With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Moderate-to-severe Atopic Dermatitis
Technische Universität Dresden 2,800
Post-approval studies (Phase 4)Looking for participantsNCT05042258
What this trial is testing

Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis

Who this might be right for
Atopic DermatitisSleep Disturbance
Northwestern University 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06727552
What this trial is testing

Barzolvolimab in Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Celldex Therapeutics 131
Large-scale testing (Phase 3)Looking for participantsNCT06807268
What this trial is testing

The Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

Who this might be right for
Eczema
Pfizer 150
Testing effectiveness (Phase 2)Study completedNCT06723405
What this trial is testing

Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)EczemaEczema Atopic Dermatitis
Evommune, Inc. 71
Testing effectiveness (Phase 2)Ended earlyNCT06881251
What this trial is testing

JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD)

Who this might be right for
Dermatitis, Atopic
Janssen Research & Development, LLC 256
Not applicableUnknownNCT05318300
What this trial is testing

Evaluation of an Adapted Formula on Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
United Pharmaceuticals 126
Testing effectiveness (Phase 2)Study completedNCT02002208
What this trial is testing

Effect of OC000459 on Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Atopix Therapeutics, Ltd. 142
Large-scale testing (Phase 3)Study completedNCT00523952
What this trial is testing

Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients

Who this might be right for
Dermatitis, Atopic
Astellas Pharma Inc 303
Testing effectiveness (Phase 2)Study completedNCT02087943
What this trial is testing

Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic Dermatitis
Amgen 191
Early research (Phase 1)Looking for participantsNCT07693738
What this trial is testing

A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
AD
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 96
Large-scale testing (Phase 3)Not Yet RecruitingNCT07479615
What this trial is testing

Evaluate the Efficacy and Safety of MG-K10 in Participants Who Have Atopic Dermatitis

Who this might be right for
Atopic DermatitisAtopic Eczema
Shanghai Mabgeek Biotech.Co.Ltd 498
Not applicableNot Yet RecruitingNCT07276620
What this trial is testing

Treatment of Moderate-to-Severe Atopic Dermatitis With Ivarmacitinib in Adolescents and Adults

Who this might be right for
Atopic Dermatitis (AD)
Xiangya Hospital of Central South University 1,000
Large-scale testing (Phase 3)Study completedNCT02277743
What this trial is testing

Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Regeneron Pharmaceuticals 671
Testing effectiveness (Phase 2)Study completedNCT02594098
What this trial is testing

Secukinumab for Treatment of Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Icahn School of Medicine at Mount Sinai 41
Large-scale testing (Phase 3)Study completedNCT06921759
What this trial is testing

Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis

Who this might be right for
Atopic Hand and Foot Dermatitis
Eli Lilly and Company 221
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation